The Main Provisions of the International Recommendations on Detection of Endocrine Hypertension
https://doi.org/10.18087/cardio.2019.10.2669
Abstract
In 2017 the Endocrine Society issued the Scientific Statement “Screening for Endocrine Hypertension" This document was developed by experts from different medical institutions of USA, Europe and Australia. Herein we present the main provisions of this Statement in the form of brief algorithm for the clinicians’ actions for timely detection of secondary endocrine hypertension and rational referral of the patient for confirmational testing.
The full text of the Scientific Statement in English is contained in the article. Young WF Jr., Calhoun DA, Lenders JW, Stowasser M, Textor SC. Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement. Endocrine Reviews. 2017; 38 (2):103-122.
URL: https://academic.oup.com/edrv/article/38/2/103/3104343
About the Authors
I. A. Vaychulis
South Ural State Medical University
Russian Federation
Russian Federation
Vaychulis Irina A. - PhD, associate professor.
Chelyabinsk
I. I. Shaposhnik
South Ural State Medical University
Russian Federation
Russian Federation
Chelyabinsk
References
1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide. Hypertension. 2004;44(4):398-404. DOI: 10.1161/01.HYP.0000142248.54761.56
2. Camelli S, Bobrie G, Postel-Vinay N, Azizi M, Plouin PF, Amar L. LB01.11: Prevalence of secondary hypertension in young hypertensive adults. Journal of Hypertension. 2015;33(Suppl 1):e47. DOI: 10.1097/01.hjh.0000467473.21331.70
3. O'Shea PM, Griffin TP, Fitzgibbon M. Hypertension: The role of biochemistry in the diagnosis and management. Clinica Chimica Acta. 2017;465:131-43. DOI: 10.1016/j.cca.2016.12.014
4. FunderJW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2016;101(5):1889-916. DOI: 10.1210/jc.2015-4061
5. Thomas RM. Endocrine hypertension: An overview on the current etiopathogenesis and management options. World Journal of Hypertension. 2015;5(2):14-27. DOI: 10.5494/wjh.v5.i2.14
6. Eisenhofer G, Pacak K, Huynh T-T, Qin N, Bratslavsky G, Linehan WM et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocrine Related Cancer. 2010;18(1):97-111. DOI: 10.1677/ERC-10-0211
7. Stolk RF, Bakx C, Mulder J, Timmers HJLM, Lenders JWM. Is the Excess Cardiovascular Morbidity in Pheochromocytoma Related to Blood Pressure or to Catecholamines? The Journal of Clinical Endocrinology & Metabolism. 2013;98(3):1100-6. DOI: 10.1210/jc.2012-3669
8. Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2014;99(6):1915-42. DOI: 10.1210/jc.2014-1498
9. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C et al. A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients. Journal of the American College of Cardiology. 2006;48(11):2293-300. DOI: 10.1016/j.jacc.2006.07.059
10. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension (Dallas, Tex.: 1979). 2002;40(6):892-6. DOI: 10.1161/01.hyp.0000040261.30455.b6
11. Catena C. Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment. Archives of Internal Medicine. 2008;168(1):80-5. DOI: 10.1001/archinternmed.2007.33
12. Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A et al. Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry. Hypertension. 2012;60(3):618-24. DOI: 10.1161/HYPERTENSIONAHA.112.197111
13. Stowasser M, Ahmed A, Pimenta E, Taylor P, Gordon R. Factors Affecting the Aldosterone/Renin Ratio. Hormone and Metabolic Research. 2012;44(3):170-6. DOI: 10.1055/s-0031-1295460
14. YangJ, Shen J, Fuller PJ. Diagnosing endocrine hypertension: a practical approach: Diagnosing endocrine hypertension. Nephrology. 2017;22(9):663-77. DOI: 10.1111/nep.13078
15. Goncharov N.P., Katsia G.V., Kolesnikova G.S. Key hormones in endocrinology and methods of their detection. -M.: Adamant; 229 p. ISBN 978-5-86103-147-9
16. Melcescu E, PhillipsJ, Moll G, SubausteJ, Koch C. 11Beta-Hydroxylase Deficiency and Other Syndromes of Mineralocorticoid Excess as a Rare Cause of Endocrine Hypertension. Hormone and Metabolic Research. 2012;44(12):867-78. DOI: 10.1055/s-0032-1321851
17. Charmandari E, Kino T, Chrousos GP. Primary Generalized Familial and Sporadic Glucocorticoid Resistance (Chrousos Syndrome) and Hypersensitivity. In: Endocrine Development Maghnie M, Loche S, Cappa M, Ghizzoni L, Lorini R, editors -Basel: S. LARGER AG;
18. Zachrisson K, Herlitz H, Lonn L, Falkenberg M, Eklof H. Duplex ultrasound for identifying renal artery stenosis: direct criteria re-evaluated. Acta Radiologica. 2017;58(2): 176-82. DOI: 10.1177/0284185116641345
19. Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM et al. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2008;93(5):1526-40. DOI: 10.1210/jc.2008-0125
20. Arapova S.D., Astafieva L.I., Babarina M.B., Belaya J.E. et al. Clinical Neuroendocrinology. edited by Dedov I.I. -M.: UP Print; 343 p. ISBN 978-5-91487-024-6
21. Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M et al. Cardiovascular Risk Factors in Patients with Uncontrolled and Long-Term Acromegaly: Comparison with Matched Data from the General Population and the Effect of Disease Control. The Journal of Clinical Endocrinology & Metabolism. 2010;95(8):3648-56. DOI: 10.1210/jc.2009-2570
22. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension. The Journal of Clinical Hypertension. 2006;8(8):596-9. DOI: 10.1111/j.1524-6175.2006.05180.x
23. Muxfeldt ES, Margallo VS, Guimaraes GM, Salles GF. Prevalence and Associated Factors of Obstructive Sleep Apnea in Patients with Resistant Hypertension. American Journal of Hypertension. 2014;27(8):1069-78. DOI: 10.1093/ajh/hpu023
Review
For citations:
Vaychulis I.A., Shaposhnik I.I. The Main Provisions of the International Recommendations on Detection of Endocrine Hypertension. Kardiologiia. 2019;59(10):88-96. (In Russ.) https://doi.org/10.18087/cardio.2019.10.2669
Views:
1410
Email this article 
Post a Comment 
